We found significantly higher numbers HER2+EVs in the plasma of patients with HER2+++ compared to HER2++/+ expression levels in breast cancer tissue that was determined by histopathological diagnosis (Fig. 4c). Here, ERBB2 is linked to breast carcinoma.